Label Changes for:

Rifater (rifampin, isoniazid and pyrazinamide) Tablets

December 2008

Changes have been made to the WARNINGS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

 

Sections Modified

Summary of Changes to Contraindications and Warnings

WARNINGS

  • Rifampin

ADVERSE REACTIONS

  • Adverse Reactions Reported for Individual Components
    • Other

WARNINGS

  • Rifampin
    • Rifampin has been shown to produce liver dysfunction. Fatalities associated with.....
Hide
(web3)